Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study
Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study
The purpose of this study is to demonstrate whether, in patients diagnosed with Vertical Heterophoria, the symptoms of dizziness, headache and / or anxiety are reduced or eliminated when a kind of correction called vertical prism is added to the patient's normal eye glass prescription.
The experiment will involve giving the patient two pairs of glasses (one pair containing the baseline prescription with vertical prism (Standard Treatment Glasses) and the other pair containing the baseline prescription but without vertical prism (Placebo Glasses)) to demonstrate which pair of glasses is most effective in reducing the symptoms of dizziness, headache and / or anxiety in these patients.
Inclusion Criteria:
First time appointment for a patient at designated optometry office for treatment of symptoms associated with Vertical Heterophoria
Must have symptoms of dizziness or headache or both:
Duration of symptoms greater than 4 months
Evaluated for these symptoms previously by at least 1 other doctor (General Practice, Family Practice, Internal Medicine, Neurology, ENT, Emergency Medicine, Pediatrics, PM&R, Ophthalmology).
Age >14
The patient (or their representative) must be able and willing to fill out extra paperwork
All Patients to be seen by same Optometrist for all visits
Must be willing to wear glasses.
The patient (or their representative) must be able to sign informed consent
Must have a driver for Follow Up visits where Control and Treatment Glasses are dispensed, and when Washout period is initiated
Must have a driver for Follow Up visits where Control and Treatment Glasses are dispensed, and when Washout period is initiated
Must have previous negative Neuroimaging (HCT or MRI) that was ordered to assess for headache and / or dizziness
Exclusion Criteria: